BioCentury
ARTICLE | Company News

Takeda to move U.S. headquarters to Boston area

September 14, 2018 5:27 PM UTC

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) will move its U.S. headquarters from Deerfield, Ill., to a to-be-determined site in the greater Boston area after its planned acquisition of Shire plc (LSE:SHP; NASDAQ:SHPG) closes next half.

Takeda spokesperson Julia Ellwanger told BioCentury the Japanese pharma decided to close Deerfield to simplify the pharma's existing U.S. operations and set up shop “closer to where our future pipeline is being generated.” The move will allow the company to bring its U.S. business units closer together to facilitate closer collaboration...